临床研究
Copyright ©The Author(s) 2021.
世界华人消化杂志. 2021-01-08; 29(1): 21-28
在线出版 2021-01-08. doi: 10.11569/wcjd.v29.i1.21
表1 双腔引流管和普通引流管患者的基本特征
参数总数 (n = 57)双腔引流管组 (n = 30)普通引流管组(n = 27)t/χ2P
年龄(岁, mean±SD)52.51±14.8754.93±13.7449.81±15.861.310.20
性别(女性)[n (%)]24 (42.11)13 (43.33)11 (40.74)0.040.84
病因[n (%)]
酒精18 (31.58)10 (33.33)8 (29.63)0.090.76
胆源性22 (38.60)12 (40.00)10 (37.04)0.050.82
特发性12 (21.05)5 (16.67)7 (25.92)0.730.39
其他原因5 (8.77)3 (10.00)2 (7.41)0.120.73
CTSI(mean±SD)9.18±1.939.30±1.979.04±1.910.500.62
疾病严重程度[n (%)]
SIRS57 (100)30 (100)27 (100)-1
持续器官衰竭数35 (61.40)19 (63.33)16 (59.26)0.100.75
血培养阳性19 (33.33)11 (36.67)8 (29.63)0.320.57
入院APACHEⅡ(分, mean±SD)15.21±3.1815.93±3.0414.41±3.201.850.07
WBC计数(×109/L)(mean±SD)15.38±3.7714.98±3.6515.82±3.92-0.840.41
表2 双腔引流管和普通引流管患者的术中及术后情况比较
参数总数(n = 57)双腔引流管组(n = 30)普通引流管组(n = 27)t/χ2P
APACHE Ⅱ入院(A)(分, mean±SD)15.21±3.1815.93±3.0414.41±3.201.850.07
APACHE Ⅱ术后引流14 d后(B)(分, mean±SD)9.16±2.837.90±2.0410.56±2.95-3.98<0.001
APACHE Ⅱ减少值(A-B)(分, mean±SD)6.05±2.798.03±2.133.85±1.298.85<0.001
1持续性器官功能衰竭逆转数[n (%)]25/35 (71.43)16/19 (84.21)9/16 (56.25)-0.132
再手术[n (%)]6 (10.52)06 (22.22)-0.008
持续引流的天数(d, mean±SD)25.72±6.5622.57±4.7529.22±6.59-4.41<0.001
严重并发症[n (%)]14 (24.56)5 (16.67)9 (33.33)2.130.14
2术后引流管通畅[n (%)]142 (84.52)60 (100)82 (75.93)17.09<0.001
手术时间(min, mean SD)169.36±28.26165.97±29.09172.00±27.39-0.800.43
术中出血量(mL, mean±SD)62.33±27.5257.33±24.5667.59±32.19-1.590.12
ICU监护时间(d, mean±SD)9.74±3.859.23±4.2310.30±3.36-1.040.30
住院时间(d, mean±SD)33.63±8.9730.57±8.8837.04±7.90-2.890.005
住院期死亡[n (%)]7 (12.28)2 (6.67)5 (18.52)1.850.17

引文著录: 党军强, 贾亭街, 张志强, 龚新利, 王浩瑜, 任彦顺. 经双腔引流管大容量灌洗并持续负压引流用于感染性胰腺坏死的疗效分析. 世界华人消化杂志 2021; 29(1): 21-28